Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 11, 2018 - Issue
Submit an article Journal homepage
57
Views
2
CrossRef citations to date
0
Altmetric
Letter

Statin on insulin and adiponectin levels: true or false prophecy?

Venu Gopal Jonnalagadda1 Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research, Bhangagarh, Guwahati, Assam, IndiaCorrespondence[email protected]
&
Afsar Shaik2 Department of Pharmacology, Narayana Pharmacy College, Chinthareddy Palem, Nellore, Andhra Pradesh, India
Pages 131-132 | Published online: 12 Apr 2018

References

  • Gruzdeva O Uchasova E Dyleva Y Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction Diabetes Metab Syndr Obes 2017 10 481 489 29255368
  • Sattar N Taskinen MR Statins are diabetogenic – myth or reality? Atheroscler Suppl 2012 13 1 10 22818818
  • Jonnalagadda VG Choudhary K Matety VK Statins and new onset of diabetes: which one outweighs risk or benefit? Postgrad Med 2018 130 1 146 29083248
  • Maki KC Diwadkar-Navsariwala V Kramer MW Statin use and risk for type 2 diabetes: what clinicians should know Postgrad Med 2017 22 1 7

Reference

  • Gruzdeva O Uchasova E Dyleva Y Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction Diabetes Metab Syndr Obes 2017 10 481 489 29255368

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.